Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Compare Drugs in Radioactive Diagnostic Agent [EPC]

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now
Drug Reports Deaths Death Rate Hosp. Life-Threat. Avg Age % Female
TECHNETIUM TC-99M SESTAMIBI 358 1 0.3% 30 10 64.1 yrs 59.1%
FLUTEMETAMOL F-18 280 1 0.4% 24 4 72.2 yrs 75.4%
GALLIUM GA-OZETOTIDE 204 4 2.0% 35 5 70.0 yrs 0.0%
PIFLUFOLASTAT F-18 191 0 N/A 3 0 69.4 yrs 3.4%
FLUDEOXYGLUCOSE F-18 139 14 10.1% 49 15 62.7 yrs 49.6%
RUBIDIUM RB-82 138 0 N/A 2 0 66.9 yrs 50.4%
TECHNETIUM TC-99M MEDRONATE 120 2 1.7% 9 3 56.8 yrs 56.3%
FLUCICLOVINE F-18 102 2 2.0% 2 0 68.3 yrs 4.3%
FLORBETAPIR F-18 99 1 1.0% 9 0 73.1 yrs 57.1%
COPPER OXODOTREOTIDE CU-64 47 0 N/A 1 0 63.2 yrs 82.1%

Head-to-Head Comparisons

TECHNETIUM TC-99M SESTAMIBI vs FLUTEMETAMOL F-18 TECHNETIUM TC-99M SESTAMIBI vs GALLIUM GA-OZETOTIDE TECHNETIUM TC-99M SESTAMIBI vs PIFLUFOLASTAT F-18 TECHNETIUM TC-99M SESTAMIBI vs FLUDEOXYGLUCOSE F-18 FLUTEMETAMOL F-18 vs GALLIUM GA-OZETOTIDE FLUTEMETAMOL F-18 vs PIFLUFOLASTAT F-18 FLUTEMETAMOL F-18 vs FLUDEOXYGLUCOSE F-18 GALLIUM GA-OZETOTIDE vs PIFLUFOLASTAT F-18 GALLIUM GA-OZETOTIDE vs FLUDEOXYGLUCOSE F-18 PIFLUFOLASTAT F-18 vs FLUDEOXYGLUCOSE F-18
← Back to Radioactive Diagnostic Agent [EPC] Class side effects →